These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1425 related items for PubMed ID: 12421111

  • 41. A phase 3 randomized, double-blind, multicenter comparative study evaluating the effect of etanercept versus methotrexate on radiographic outcomes, disease activity, and safety in Japanese subjects with active rheumatoid arthritis.
    Takeuchi T, Miyasaka N, Zang C, Alvarez D, Fletcher T, Wajdula J, Yuasa H, Vlahos B.
    Mod Rheumatol; 2013 Jul; 23(4):623-33. PubMed ID: 23011358
    [Abstract] [Full Text] [Related]

  • 42. Etanercept: therapeutic use in patients with rheumatoid arthritis.
    Garrison L, McDonnell ND.
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I65-9. PubMed ID: 10577976
    [Abstract] [Full Text] [Related]

  • 43. Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis.
    Hochberg MC, Tracy JK, Hawkins-Holt M, Flores RH.
    Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii13-6. PubMed ID: 14532140
    [Abstract] [Full Text] [Related]

  • 44. Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.
    Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic DS, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Johnson A, Huang B, Lovell DJ, Childhood Arthritis and Rheumatology Research Alliance (CARRA).
    J Rheumatol; 2014 Jun; 41(6):1163-70. PubMed ID: 24786928
    [Abstract] [Full Text] [Related]

  • 45. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.
    Mease PJ, Kivitz AJ, Burch FX, Siegel EL, Cohen SB, Ory P, Salonen D, Rubenstein J, Sharp JT, Tsuji W.
    Arthritis Rheum; 2004 Jul; 50(7):2264-72. PubMed ID: 15248226
    [Abstract] [Full Text] [Related]

  • 46. Etanercept: long-term clinical experience in rheumatoid arthritis and other arthritis.
    Cobo-Ibáñez T, Martín-Mola E.
    Expert Opin Pharmacother; 2007 Jun; 8(9):1373-97. PubMed ID: 17563271
    [Abstract] [Full Text] [Related]

  • 47. Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study.
    van Riel PL, Taggart AJ, Sany J, Gaubitz M, Nab HW, Pedersen R, Freundlich B, MacPeek D, Add Enbrel or Replace Methotrexate Study Investigators.
    Ann Rheum Dis; 2006 Nov; 65(11):1478-83. PubMed ID: 16464988
    [Abstract] [Full Text] [Related]

  • 48. A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China.
    Hu D, Bao C, Chen S, Gu J, Li Z, Sun L, Han X, Ni L.
    Rheumatol Int; 2009 Jan; 29(3):297-303. PubMed ID: 18704426
    [Abstract] [Full Text] [Related]

  • 49. Response times follow lognormal or gamma distribution in arthritis patients.
    Abrahamyan L, Beyene J, Feng J, Chon Y, Willan AR, Schmeling H, Horneff G, Keystone EC, Feldman BM.
    J Clin Epidemiol; 2010 Dec; 63(12):1363-9. PubMed ID: 20430577
    [Abstract] [Full Text] [Related]

  • 50. Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan.
    Mori M, Takei S, Imagawa T, Imanaka H, Nerome Y, Higuchi R, Kawano Y, Yokota S, Sugiyama N, Yuasa H, Fletcher T, Wajdula JS.
    Mod Rheumatol; 2012 Sep; 22(5):720-6. PubMed ID: 22212889
    [Abstract] [Full Text] [Related]

  • 51. Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate.
    Kavanaugh A, Klareskog L, van der Heijde D, Li J, Freundlich B, Hooper M.
    Ann Rheum Dis; 2008 Oct; 67(10):1444-7. PubMed ID: 18535115
    [Abstract] [Full Text] [Related]

  • 52. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
    Shepherd J, Cooper K, Harris P, Picot J, Rose M.
    Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
    [Abstract] [Full Text] [Related]

  • 53. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H, Mayer PR, Wajdula J, Fatenejad S.
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [Abstract] [Full Text] [Related]

  • 54. Etanercept in arthritis.
    Scott DL.
    Int J Clin Pract; 2005 Jan; 59(1):114-8. PubMed ID: 15707475
    [Abstract] [Full Text] [Related]

  • 55. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
    Keystone EC, Kavanaugh AF, Sharp JT, Tannenbaum H, Hua Y, Teoh LS, Fischkoff SA, Chartash EK.
    Arthritis Rheum; 2004 May; 50(5):1400-11. PubMed ID: 15146409
    [Abstract] [Full Text] [Related]

  • 56. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.
    Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, Singh A, Pedersen RD, Koenig AS, Freundlich B.
    Lancet; 2008 Aug 02; 372(9636):375-82. PubMed ID: 18635256
    [Abstract] [Full Text] [Related]

  • 57. Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study.
    Furst DE, Gaylis N, Bray V, Olech E, Yocum D, Ritter J, Weisman M, Wallace DJ, Crues J, Khanna D, Eckel G, Yeilding N, Callegari P, Visvanathan S, Rojas J, Hegedus R, George L, Mamun K, Gilmer K, Troum O.
    Ann Rheum Dis; 2007 Jul 02; 66(7):893-9. PubMed ID: 17412737
    [Abstract] [Full Text] [Related]

  • 58. Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial.
    Kameda H, Ueki Y, Saito K, Nagaoka S, Hidaka T, Atsumi T, Tsukano M, Kasama T, Shiozawa S, Tanaka Y, Takeuchi T, Japan Biological Agent Study Integrated Consortium.
    Mod Rheumatol; 2010 Dec 02; 20(6):531-8. PubMed ID: 20574649
    [Abstract] [Full Text] [Related]

  • 59. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
    Strober BE, Clarke S.
    J Drugs Dermatol; 2004 Dec 02; 3(3):270-2. PubMed ID: 15176161
    [Abstract] [Full Text] [Related]

  • 60. Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial.
    Weinblatt M, Schiff M, Goldman A, Kremer J, Luggen M, Li T, Chen D, Becker JC.
    Ann Rheum Dis; 2007 Feb 02; 66(2):228-34. PubMed ID: 16935912
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 72.